These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 14555514)

  • 41. Evaluation of three mRNA markers for the detection of lymph node metastases.
    Berger J; Mueller-Holzner E; Fiegl H; Marth C; Daxenbichler G
    Anticancer Res; 2006; 26(5B):3855-60. PubMed ID: 17094413
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of antisense DNMT3b gene eukaryotic expression plasmid on expression of the DNMT3b gene in human biliary tract carcinoma cells.
    Zuo S; Dong JQ; Guo W; Liu MF; Xu LN; Luo J; Zou SQ
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):123-8. PubMed ID: 16481298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
    Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD
    Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene expression and promoter polymorphisms of DNA methyltransferase 3B in nasopharyngeal carcinomas in Taiwanese people: a case-control study.
    Chang KP; Hao SP; Tsang NM; Chang YL; Cheng MH; Liu CT; Lee YS; Tsai CL; Lee TJ; Wang TH; Tsai CN
    Oncol Rep; 2008 Jan; 19(1):217-22. PubMed ID: 18097598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of Delta DNMT3B variants and its association with promoter methylation of p16 and RASSF1A in primary non-small cell lung cancer.
    Wang J; Walsh G; Liu DD; Lee JJ; Mao L
    Cancer Res; 2006 Sep; 66(17):8361-6. PubMed ID: 16951144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
    Søiland H; Skaland I; Varhaug JE; Kørner H; Janssen EA; Gudlaugsson E; Baak JP; Søreide JA
    Acta Oncol; 2009; 48(4):514-21. PubMed ID: 19107621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis.
    Wu Y; Strawn E; Basir Z; Halverson G; Guo SW
    Fertil Steril; 2007 Jan; 87(1):24-32. PubMed ID: 17081533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction.
    Iwao K; Miyoshi Y; Egawa C; Ikeda N; Tsukamoto F; Noguchi S
    Cancer; 2000 Oct; 89(8):1732-8. PubMed ID: 11042568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic value of ERBB family mRNA expression in breast carcinomas.
    Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R
    Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma.
    Bièche I; Girault I; Urbain E; Tozlu S; Lidereau R
    Breast Cancer Res; 2004; 6(3):R252-63. PubMed ID: 15084249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA methyltransferases 1, 3a, and 3b overexpression and clinical significance in gastroenteropancreatic neuroendocrine tumors.
    Rahman MM; Qian ZR; Wang EL; Yoshimoto K; Nakasono M; Sultana R; Yoshida T; Hayashi T; Haba R; Ishida M; Okabe H; Sano T
    Hum Pathol; 2010 Aug; 41(8):1069-78. PubMed ID: 20381114
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer.
    Ariazi EA; Clark GM; Mertz JE
    Cancer Res; 2002 Nov; 62(22):6510-8. PubMed ID: 12438245
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of associations between the patterns of global DNA hypomethylation and expression of DNA methyltransferase in patients with systemic lupus erythematosus.
    Zhu X; Liang J; Li F; Yang Y; Xiang L; Xu J
    Int J Dermatol; 2011 Jun; 50(6):697-704. PubMed ID: 21595664
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation.
    Chang HC; Cho CY; Hung WC
    Cancer Res; 2006 Sep; 66(17):8413-20. PubMed ID: 16951151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in tamoxifen-treated breast cancer patients.
    Jahangiri R; Jamialahmadi K; Gharib M; Emami Razavi A; Mosaffa F
    Gene; 2019 Feb; 685():24-31. PubMed ID: 30359738
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cigarette smoke induces demethylation of prometastatic oncogene synuclein-gamma in lung cancer cells by downregulation of DNMT3B.
    Liu H; Zhou Y; Boggs SE; Belinsky SA; Liu J
    Oncogene; 2007 Aug; 26(40):5900-10. PubMed ID: 17369845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells.
    Kassis ES; Zhao M; Hong JA; Chen GA; Nguyen DM; Schrump DS
    J Thorac Cardiovasc Surg; 2006 Feb; 131(2):298-306. PubMed ID: 16434257
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RNA interference-mediated knockdown of DNMT1 and DNMT3B induces CXCL12 expression in MCF-7 breast cancer and AsPC1 pancreatic carcinoma cell lines.
    Sowińska A; Jagodzinski PP
    Cancer Lett; 2007 Sep; 255(1):153-9. PubMed ID: 17532557
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas.
    Bièche I; Girault I; Sabourin JC; Tozlu S; Driouch K; Vidaud M; Lidereau R
    Br J Cancer; 2003 Mar; 88(6):863-70. PubMed ID: 12644823
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DNA repair gene expression and risk of locoregional relapse in breast cancer patients.
    Le Scodan R; Cizeron-Clairac G; Fourme E; Meseure D; Vacher S; Spyratos F; de la Lande B; Cvitkovic F; Lidereau R; Bieche I
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):328-36. PubMed ID: 20092964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.